Search Results - Iltefat H Hamzavi

Evaluating the Impact of Exclusion Criteria on the Generalizability of Hidradenitis Suppurativa Treatment Research by Jalal Maghfour, Vivian Liu, Angela Parks-Miller, Iltefat H. Hamzavi

Connect to this object online.

Psychometric Evaluation of the Facial and Total Vitiligo Area Scoring Index Instruments in the TRuE-V Phase 3 Studies by Kristen Bibeau, Kathleen Butler, Mingyue Wang, Konstantina Skaltsa, Iltefat H. Hamzavi

Connect to this object online.

The role of sunscreen in melasma and postinflammatory hyperpigmentation by Sakeena Fatima, Taylor Braunberger, Tasneem F Mohammad, Indermeet Kohli, Iltefat H Hamzavi

Connect to this object online.

Infusion reaction to infliximab biosimilar after transitioning from infliximab by Reem Kashlan, MPH, Alexis B. Lyons, MD, Shanthi Narla, MD, Iltefat H. Hamzavi, MD

Connect to this object online.

T-cell/histiocyte-rich large B-cell lymphoma in a 27-year-old with hidradenitis suppurativa, psoriasis, and vitiligo: Implications for screening by Gautham Vellaichamy, MD, Steven M. Townsend, MD, Alexis B. Lyons, MD, Iltefat H. Hamzavi, MD

Connect to this object online.

Association of myalgias with compounded topical Janus kinase inhibitor use in vitiligo by Shanthi Narla, MD, Sandra Oska, BA, Alexis B. Lyons, MD, Henry W. Lim, MD, Iltefat H. Hamzavi, MD

Connect to this object online.

Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years by John E. Harris, Amit G. Pandya, Mark Lebwohl, Iltefat H. Hamzavi, Pearl Grimes, Alice B. Gottlieb, Howard L. Sofen, Angela Y. Moore, Mingyue Wang, Deanna Kornacki, Kathleen Butler, David Rosmarin

Connect to this object online.